Intergrated analysis of CYP3A5 and ABCB1 gene polymorphisms in renal transplanted recipients treated by Tacrolimus
- Author:
- No author available
- Journal Title:
- Chinese Journal of Organ Transplantation
- Issue:
- 12
- DOI:
- 10.3760/cma.j.issn.0254-1785.2015.12.007
- Key Word:
- 他克莫司;肾移植;CYP3A5;ABCB1;基因多态性;Tacrolimus;Kidney transplantation;CYP3A5;ABCB1;Genetic polymorphism
Abstract： Objective To approach the effect of CYP3A5 6986A＞G (rs776746) and ABCB1 3435C＞T (rs104564) on plasma tacrolimus(FK506) dose adjusted blood trough concentrations(C0/D) in kidney transplanted patients.Method Totally 125 renal transplanted recipients were recruited,and gene sequencing method were used to detect the genotype of CYP3A5 6986A＞G and ABCB1 3435C＞ T.FK506 trough concentration of 125 patients was detected by enzyme multiplies immunoassay technique (EMIT) after the surgery over 6 month.The relevance between the ratio of trough concentration/dosage and polymorphisms was analyzed.Result In 125 renal transplanted receipients,the allele frequency of CYP3A5 and ABCB1 genetic variants was 74％ and 34.8％,respectively.After 6 months,the C0/D ration in the homozygous mutant CYP3A5 * 3/* 3 receiptients was significant higher than that in the homozygous wild type * 1/* 3 and heterozygous mutant * 1/* 1 receiptients (P ＜ 0.05).And there was no significant difference of the Co/D ration between CYP3A5 * 1/* 1 and CYP3A5 * 1/* 3 receipients(P＞0.05).The the C0/D ration in homozygous wild type ABCB1 T/T and homozygous mutant T/C receipients was significant higher than that in heterozygous mutant C/C receipients (P＜0.05),and there was no significant difference of the C0/D ration between T/C and T/T receipients (P＞ 0.05).Conclusion The study shows that the the polymorphism of CYP3A5 and ABCB1 genes was significantly correlated with the trough C0/D value of the recipients after renal transplantation who were treated by Tacrolimus for more than half a year.The detection of the SNP of the CYP3A5 and ABCB1 will be useful for FK506 dosage adjustment.
- [1]张海燕,张小明,吴小丽,等.CYP3A5基因多态性对中国肾移植受者他克莫司血药浓度和疗效的影响[J].2011,(6).
- [2]Gervasini,G.,Garcia,M.,MacIas,R.M.,etc.Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation[J].2012,25(4).
- [3]Yi Li,Xin Hu,Bei Cai,etc.Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipient[J].2012,27(1).
- [4]MacPhee,I.A.M..Pharmacogenetic biomarkers: Cytochrome P450 3A5[J].2012,413(17).
- [5]Srivastava A,Kapoor R,Singh R.Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India.[J].2009,380(2).
- [6]Staatz CE,Goodman LK,Tett SE.Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.[J].2010,49(4).
- [7]Utecht KN,Kolesar J,Hiles JJ.Effects of genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors.[J].2006,63(23).
- [8]Huang Z,Nie X,Gui R,etc.Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.[J].2006,38(9).
- [9]Liu L,Zhang X,Zhang J,etc.Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients.[J].2010,42(9).
- [10]Gaston RS.Maintenance immunosuppression in the renal transplant recipient: an overview.[J].2001,38(Suppl.6).
- [11].Population pharmacokinetic modelling and design of a bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation[J].2012,51(3).
- [12]Kuypers DR,de-Jonge H,Naesens M,etc.CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.[J].2007,82(6).
- [13]Lindemans J,van der Heiden IP,Gregoor PJ,etc.Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus.[J].2003,74(3).
- [14]Ayna,T.K.,Nane,I.,Bakkaloglu,H.,etc.Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients[J].2013,45(3).
- [15]de Jonge H,Kuypers DR.Pharmacogenetics in solid organ transplantation: current status and future directions.[J].2008,22(1).